MedTrace Logo

WOMAC Hip Score in Children and Adolescents With Perthes Disease

NCT02795494 · Status: UNKNOWN · Type: OBSERVATIONAL · Enrollment: 200

Last updated 2016-06-10

No results posted yet for this study

Summary

Patient oriented clinical outcomes have increased in use and popularity and provide a comprehensive assessment of the level of symptoms and function experienced by a patient. Though several measures have been developed and shown to be valid, reliable, and responsive in adults, such efforts have only been rarely undertaken in pediatric populations. Specifically, there has been no validation of the predominant adult hip specific outcome measures, such as the WOMAC and Oxford-12, in children and adolescents. Prior to using such measures in pediatric patients, it is necessary to establish the psychometric properties of these measurements in this population.

The objective of this study is to determine the reliability and validity of the WOMAC hip scores in a pediatric population, between five and nineteen years of age, with Perthes disease. The results of this study will accomplish the above goal, thereby allowing either for widespread use of these measures in pediatric hip disorders or emphasizing the necessity for development of a pediatric hip specific outcome measure.

Conditions

  • Legg-Calvé-Perthes Disease

Interventions

BEHAVIORAL

WOMAC questionnaire at baseline

Patient-reported pain, stiffness and physical function outcome score

BEHAVIORAL

ASK-P questionnaire at baseline

Patient-reported activity level score

BEHAVIORAL

WOMAC questionnaire at 2 weeks

Patient-reported pain, stiffness and physical function outcome score

Sponsors & Collaborators

  • British Columbia Children's Hospital

    lead OTHER

Principal Investigators

  • Kishore Mulpuri, MBBS, MS(Ortho), MHSc · Provincial Health Services Authority

Eligibility

Min Age
5 Years
Max Age
19 Years
Sex
ALL
Healthy Volunteers
Yes

Timeline & Regulatory

Start
2007-05-31
Primary Completion
2020-05-31
Completion
2020-05-31

Countries

  • Canada

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT02795494 on ClinicalTrials.gov